|
C6ORF134 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.623400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.938800E-01 |
| Normal-vs-Stage2 |
7.890400E-02 |
| Normal-vs-Stage3 |
6.315800E-02 |
| Normal-vs-Stage4 |
5.255800E-01 |
| Stage1-vs-Stage2 |
7.059700E-02 |
| Stage1-vs-Stage3 |
3.682400E-02 |
| Stage1-vs-Stage4 |
4.465000E-01 |
| Stage2-vs-Stage3 |
7.828800E-01 |
| Stage2-vs-Stage4 |
4.499800E-01 |
| Stage3-vs-Stage4 |
5.351600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.658600E-01 |
| Normal-vs-AfricanAmerican |
7.477600E-01 |
| Normal-vs-Asian |
1.300430E-01 |
| Caucasian-vs-AfricanAmerican |
5.160800E-01 |
| Caucasian-vs-Asian |
3.020200E-02 |
| AfricanAmerican-vs-Asian |
3.931200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.589200E-01 |
| Normal-vs-Female |
3.146400E-01 |
| Male-vs-Female |
6.372400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.975400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.145800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.447700E-02 |
| Normal-vs-Age(81-100Yrs) |
7.797200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.729800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.536420E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.441000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.486200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.650000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.851400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.24299995138711E-09 |
| Classical-VS-Follicular |
2.39089999999331E-05 |
| Classical-VS-Other |
9.970200E-01 |
| Classical-VS-Normal |
4.292200E-01 |
| Tall-VS-Follicular |
1.800580E-01 |
| Tall-VS-Other |
2.109400E-01 |
| Tall-VS-Normal |
1.6888100000001E-05 |
| Follicular-VS-Other |
1.991650E-01 |
| Follicular-VS-Normal |
4.658600E-03 |
| Other-VS-Normal |
8.651000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.685000E-01 |
| Normal-vs-N1 |
2.732600E-01 |
| N0-vs-N1 |
4.134400E-02 |
|
|
